Recurrent Herpes Labialis Clinical Trial
Official title:
A Randomized, Multicenter, Double-Blinded Controlled Study to Compare the Effectiveness of a Single Dose (1500 mg) of Famciclovir, One Day (750 mg q12) of Famciclovir and Placebo in Patient-Initiated Episodic Treatment of Recurrent Herpes Labialis
The study is designed to assess the efficacy and safety of patient-initiated therapy with famciclovir 1500 mg o.d. or 750 mg b.i.d. for one day treatment in adult men and women with recurrent herpes labialis
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03977792 -
An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
|
Phase 2 | |
| Active, not recruiting |
NCT05098938 -
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
|
Phase 3 | |
| Completed |
NCT01985321 -
Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores
|
Phase 2 | |
| Completed |
NCT03192306 -
Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores
|
Phase 2 | |
| Completed |
NCT01324466 -
A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)
|
Phase 3 | |
| Completed |
NCT00914745 -
Place Controlled Study to Treat Recurrent Herpes Labialis.
|
Phase 2 |